We are monitoring the impact of COVID-19 on APAC Thyroid cancer Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2170
Share on
Share on

Asia Pacific Thyroid Cancer Market Research Report – Segmented By Treatment, End User and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2170
Pages: 140

APAC Thyroid Cancer Market Size (2021 to 2026)

As per our report, the size of the Asia Pacific Thyroid Cancer Market was valued at USD 60.37 million in 2021 and is expected to grow at a CAGR of 30.16% to reach USD 225.53 million by 2026.

Thyroid cancer is basically treated by surgery and radiotherapy. Chemotherapy has fewer roles in the treatment. Doxorubicin is said to be used as an off-label drug for treating plastic thyroid cancer patients. In the same way some other off-name medications, for example, carboplatin and cisplatin are used, however response rates have come down because of them. It can be concluded that Asia Pacific Thyroid Cancer Market is expected to have a high growth rate.

Asia Pacific Thyroid Cancer Market is strong because it consists of 27 molecules that are in different stages of development. There are four molecules in Pre-registration (1) and Phase III (3). These drugs mostly get approved in the next 7 years.  XL184, Zactima, and Zybrestat have been granted orphan drug status by the FDA.

Once the above molecules get approved, it will intensify competition in the market which in turn results in substantial growth in market. Current competition in Asia Pacific Thyroid Cancer Market is very less. Some effective treatments like surgery exist and chemotherapy drugs can be used. Companies such as Doxorubicin which aim at managing conditions are prone to get larger success in the future.

This research report on the Asia Pacific Thyroid Cancer Market segmented and sub-segmented into the following categories.

By Treatment:

  • Surgery
  • Iodine Therapy
  • External Therapy
  • Thyroxine treatment
  • Chemotherapy
  • Drugs

By Drug: 

  • Levothyroxine
  • Radioiodine

By End User: 

  • Hospitals
  • Oncology Centres
  • Hospital Pharmacies
  • Retail Pharmacies

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Noteworthy players dominating the APAC Thyroid Cancer Market profiled in this report are Baxter International Inc., Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co, Abbott laboratories, Teva parenteral medicines Inc., App pharmaceuticals LLC, and Jerome Stevens Pharmaceuticals Inc.


                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Treatment                                                  

                                5.1.1 Introduction                                           

                                5.1.2 Surgery                                     

                                5.1.3 Iodine Theraphy                                   

                                5.1.4 External radiotherapy                                        

                                5.1.5 Thyroxine treatment                                          

                                5.1.6  chemotherapy                                     

                                5.1.7 Drugs                                         

                                5.1.8  Y-o-Y Growth Analysis, By Treatment                                         

                                5.1.9  Market Attractiveness Analysis, By Treatment                                       

                                5.1.10 Market Share Analysis, By Treatment                                       

                5.2 End User      

                                5.2.1 Introduction                                           

                                5.2.2 Hospital                                    

                                5.2.3 Oncology centers                                 

                                5.2.4 Hospital Pharmacies                                            

                                5.2.5 Retail Pharmacies                                 

                                5.2.6 Y-o-Y Growth Analysis, By End User                                             

                                5.2.7 Market Attractiveness Analysis, By End User                                           

                                5.2.8 Market Share Analysis, By End User                                             

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                       By Geographical Area                     

                                       By Treatment                     

                                       By End User                        

                                6.1.4  Market Attractiveness Analysis     

                                       By Geographical Area                     

                                       By Treatment                     

                                       By End User                        

                                6.1.5  Market Share Analysis      

                                       By Geographical Area                     

                                       By Treatment                     

                                       By End User                        

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

                6.6 Australia                                                      

7.Strategic Analysis                                                                        

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                                                                         

                8.1 Baxter International Inc                                                        

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Mylan pharmaceuticals Inc                                                  

                8.3 Alara Pharmaceutical Corporation                                                    

                8.4  Bristol Myers co                                                       

                8.5  Abbott laboratories                                                               

                8.6 Teva parenteral medicines Inc                                                           

                8.7 App pharmaceuticals llc                                                         

                8.8  Jerome Stevens Pharmaceuticals Inc                                                             

9.Competitive Landscape                                                                            

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10.Market Outlook and Investment Opportunities                                                                          


                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Thyroid Cancer Market, By Treatment, From 2021 to 2026 (USD Million)
  2. Asia Pacific Surgery Market, By Region, From 2021 to 2026 (USD Million)
  3. Asia Pacific Iodine Theraphy Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia Pacific External radiotherapy Market, By Region, From 2021 to 2026 (USD Million)
  5. Asia Pacific Thyroxine treatment Market, By Region, From 2021 to 2026 (USD Million)
  6. Asia Pacific chemotherapy Market, By Region, From 2021 to 2026 (USD Million)
  7. Asia Pacific Drugs Market, By Region, From 2021 to 2026 (USD Million)
  8. Asia Pacific Thyroid Cancer Market, By End User, From 2021 to 2026 (USD Million)
  9. Asia Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  10. Asia Pacific Oncology Centers Market, By Region, From 2021 to 2026 (USD Million)
  11. Asia Pacific Hospital Pharmacies Market, By Region, From 2021 to 2026 (USD Million)
  12. Asia Pacific Retail Pharmacies Market, By Region, From 2021 to 2026 (USD Million)
  13. Japan Thyroid Cancer Market, By Treatment, From 2021 to 2026 (USD Million)
  14. Japan Thyroid Cancer Market, By End User, From 2021 to 2026 (USD Million)
  15. China Thyroid Cancer Market, By Treatment, From 2021 to 2026 (USD Million)
  16. China Thyroid Cancer Market, By End User, From 2021 to 2026 (USD Million)
  17. India Thyroid Cancer Market, By Treatment, From 2021 to 2026 (USD Million)
  18. India Thyroid Cancer Market, By End User, From 2021 to 2026 (USD Million)
  19. Australia Thyroid Cancer Market, By Treatment, From 2021 to 2026 (USD Million)
  20. Australia Thyroid Cancer Market, By End User, From 2021 to 2026 (USD Million)
  21. South Korea Thyroid Cancer Market, By Treatment, From 2021 to 2026 (USD Million)
  22. South Korea Thyroid Cancer Market, By End User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample